The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery

Description

This project intends to more thoroughly investigate the direct influence of Pecs blocks in the administration of Exparel, a non-opioid analgesic, in breast reconstruction surgery. The hypothesis is that this analgesic delivery method will significantly reduce negative outcomes such as post-operative pain, opioid use, and nausea while increasing positive outcomes such as post-operative physical activity.

Conditions

Mammaplasty

Talk to us

Study Overview

On this page

Study Details

Study overview

This project intends to more thoroughly investigate the direct influence of Pecs blocks in the administration of Exparel, a non-opioid analgesic, in breast reconstruction surgery. The hypothesis is that this analgesic delivery method will significantly reduce negative outcomes such as post-operative pain, opioid use, and nausea while increasing positive outcomes such as post-operative physical activity.

A Prospective, Randomized Controlled Trial Investigating Pecs Blocks Types I and II as a Method for Administering the Non-Opioid Anesthetic Exparel in Order to Mitigate Postoperative Narcotic Usage, Pain, Nausea, and Hospital Stay in Patients Undergoing Implant-Based Tissue Expander Breast Reconstruction Surgery

The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery

Condition
Mammaplasty
Intervention / Treatment

-

Contacts and Locations

Chicago

Northwestern Memorial Hospital, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Subjects greater than 18 years of age.
  • 2. Subject who are undergoing implant-based, tissue expander breast reconstruction surgery.
  • 1. Subjects undergoing flap breast reconstruction.
  • 2. Subjects who are undergoing direct-to-implant surgery.
  • 3. Subjects who have previously undergone radiation therapy.
  • 4. Medical or psychiatric condition that may increase the risk associated with study participation, may complicate patient compliance, or may interfere with the interpretation of study results and, in the judgment of the Investigator, would make the subject inappropriate for entry into this study.
  • 5. Subjects who are pregnant at the date of surgery.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Northwestern University,

Robert Galiano, MD, PRINCIPAL_INVESTIGATOR, 3126956022

Study Record Dates

2024-04